SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

3 Nov 2020 07:00

RNS Number : 0174E
Coats Group PLC
03 November 2020
 

3 November 2020

LEI: 2138003SPYWGAITNFY17

 

Coats Group plc

Trading Update

Continued improving sales trend; 2020 adjusted operating profit ahead of market expectations

Coats Group plc ('Coats,' the 'Company' or the 'Group'), the world's leading industrial thread manufacturer, today updates on trading for the period 1 July 2020 to 31 October 2020 ("the period").

 

 

Overview

 

·

Group CER sales for the period down 9% year-on-year (H1: down 21%).

·

Improving demand trend seen across both Apparel and Footwear and Performance Materials, notably into the start of the peak trading period of September to November.

·

Further incremental new customer wins and share gains from competitors as we leverage our global footprint, flexibility and digital tools to deliver high levels of customer service.

·

As a result of the improving trading performance seen in the period, we anticipate Group adjusted operating profit for 2020 to be ahead of market expectations and in the range of $100 - 110 million.

·

Balance Sheet remains strong; cash generation in the period ahead of expectations; September net debt $211 million (excluding IFRS16).

·

Continued encouraging trading performance in the period, although mindful that uncertainties remain around the recovery profile of our various global end markets into 2021.

 

 

Year-on-year sales performance

 

July to October

H1 2020

Reported

CER

sales*

Organic

sales**

Reported

 

CER

sales*

Organic

sales**

Apparel & Footwear

(17)%

(15)%

(15)%

(31)%

(29)%

(29)%

Performance Materials

9%

10%

(13)%

(1)%

2%

(19)%

Group

(11)%

(9)%

(15)%

(24)%

(21)%

(26)%

 

Group CER sales for the period declined 9% year-on-year, which reflected 15% organic decline and a 6% contribution from the acquisition of Pharr High Performance Yarns (Pharr HP) which was bought in February. The 9% year-on-year CER decline consisted of 15% decline in Apparel and Footwear (A&F), with some offset from Performance Materials (PM) which grew 10% (including the initial contribution from Pharr HP). On a reported basis Group sales for the period declined 11%; the marginal headwind vs CER rates being due to the depreciation in the Indian Rupee, Brazilian Real, and Turkish Lira.

On an organic basis there was an improving trend during the period, including into the first 2 months of the peak trading period of September to November. The combined September and October organic decline at a Group level improved to around 11%, compared to 15% for the trading period.

Apparel and Footwear showed continued performance improvement throughout the period. This follows the first half in which sales were significantly impacted by brands and manufacturers cancelling or deferring orders from mid-March, as well as enforced government lockdowns affecting a number of our sites. Our manufacturing footprint is now effectively fully operational and we have seen an encouraging improvement in brand and manufacturer order confidence into the peak trading season of September-November where production is primarily for the spring/summer 2021 season. Heightened industry inventory levels from significant Covid-related market disruption in the first half appear to be clearing this year broadly as we anticipated.

Performance Materials reported CER sales growth in the period of 10% which comprised an organic sales decline of 13% and a 23% contribution from Pharr HP, which was acquired in February. Transportation achieved year-on-year growth, as demand improved along with the benefit of new customer wins. In addition, Household and Recreation sales were ahead of prior year, underpinned by improved demand for bedding and other home textiles. Sales in Personal Protection and Telecoms and Energy were slower in the period than in the first half of the year, but these sectors remain key medium-term growth drivers for the PM division, underpinned by attractive industry fundamentals (for example, the 5G infrastructure roll out).

Our unwavering focus on supporting customers through these difficult times continues to deliver incremental new customer wins as we are able to leverage our global footprint, flexibility and customer service offering to deliver high quality products at speed. The Apparel and Footwear industry continues to focus on accelerating its sustainability agenda, and as such we have seen significantly increasing levels of demand for our sustainable product range, EcoVerde, with year-to-date sales around 6 times higher than 2019 levels. In addition we have continued to make progress with our innovation programme with 9 further new product launches in the period (H1: 13 new product launches).

 

Balance Sheet and cash update

We entered 2020 with a robust Balance Sheet, generating healthy levels of cash, and with comfortable headroom on our banking covenants, which place us in a strong position to manage through the Covid uncertainty.

As expected in the trading period, we initially saw an increase to Group net debt in July and August, as lower levels of collections in Q3 (driven by lower Q2 sales levels) were exceeded by monthly recurring payments, as well as the impact of the deferral of $12 million indirect and direct tax payments (as part of government COVID schemes) from H1 into H2. Since that initial increase in net debt in July and August, we have seen an encouraging improvement in our cash generation due to the ongoing recovery in trading conditions and normalisation of working capital days, and as a result have seen a reduction in net debt during the month of September. As at 30 September 2020 our net debt (excluding IFRS16) was $211 million, which compared to $207 million at 30 June 2020.

Our committed debt facilities total $575 million across our Banking and US Private Placement group, with a range of maturities from late 2022 through to 2027, and we currently have around $300 million of committed headroom against these banking facilities. Our close focus on cost and cash during 2020 will enable us to selectively invest in the most attractive organic and inorganic investments amidst the recovery from Covid, in order to drive incremental shareholder value.

 

Dividend

The Board is mindful of the importance of income to shareholders and as performance continues to progress, it will keep future dividends, including the final 2020 dividend, under review with any decision to be announced alongside the FY20 results in March 2021.

 

Outlook

As a result of the improving trading performance seen in the period, in particular the start of the peak trading period in September and October, we anticipate Group adjusted operating profit for 2020 to be ahead of market expectations and in the range of $100 - 110 million.

 

The improving performance seen to date and trading outlook for the remainder of 2020 remains encouraging, however, we are mindful that uncertainties related to Covid remain around the recovery profile of our various global end markets as we look into 2021.

 

 

 

 

 

 

 

This announcement contains inside information for the purposes of the Market Abuse Regulation.

 

Constant exchange rate (CER) figures are 2019 restated at 2020 exchange rates.  

**Organic growth is on a CER basis excluding contributions from bolt-on acquisitions (Pharr).  

 

_________________________________________________________________________________________

 

Enquiry details

 

Investors

Rob Mann

Coats Group plc

+44 (0)20 8210 5175

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

_________________________________________________________________________________________

 

About Coats Group plc

Coats is the world's leading industrial thread company. At home in some 50 countries, Coats has a workforce of 17,000 people across six continents. Revenues in 2019 were US$1.4bn. Coats' pioneering history and innovative culture ensure the company continues leading the way around the world. It provides complementary and value added products, services and software solutions to the apparel and footwear industries. It applies innovative techniques to develop high technology Performance Materials threads, yarns and fabrics in areas such as Transportation, Telecommunications and Energy, and Personal Protection. Headquartered in the UK, Coats is a FTSE 250 company, a constituent of the FTSE4Good Index Series and a participant in the UN Global Compact. To find out more about Coats visit www.coats.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKBBPKBDBPDK
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.